Hims Hers Health Inc
For the period ended Dec 31, 2023. Filed Feb 26, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 26, 2024
HIMS$19.13-16.6%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statement of Mezzanine Equity and Stockholders’ Equity (Deficit)
Consolidated Statements of Mezzanine Equity and Stockholders' Equity (Deficit)
(In Thousands, Except Share Data)
| Redeemable Convertible Preferred Stock · Common Stock · AdditionalPaid-InCapital · AccumulatedOtherComprehensiveIncome (Loss) · AccumulatedDeficit · TotalStockholders' Equity (Deficit) | ||||||||
|---|---|---|---|---|---|---|---|---|
| Shares · Amount · Shares · Amount | ||||||||
| Balance as of December 31, 2020 | 93,328,118 | $249,962 | 52,967,106 | $5 | $24,424 | $(11) | $(171,292) | $(146,874) |
| Pre-closing stock repurchase, net of exercise of vested options | (206,511) | (125) | (1,817,519) | — | (21,902) | — | — | (21,902) |
| Conversion of redeemable convertible preferred stock to common stock | (93,121,607) | (249,837) | 93,121,607 | 9 | 249,828 | — | — | 249,837 |
| Repayment of related-party promissory notes associated with vested shares | — | — | — | — | 854 | — | — | 854 |
| Forfeiture of related-party promissory notes | — | — | (370,734) | — | — | — | — | — |
| Conversion of Series D preferred stock warrants to Class A common warrants | — | — | — | — | 1,160 | — | — | 1,160 |
| Exercise of Class A common stock warrants | — | — | 1,867,380 | — | 21,679 | — | — | 21,679 |
| Issuance of common stock upon Merger, net of transaction costs of $18.7 million | — | — | 24,142,244 | 2 | 129,657 | — | — | 129,659 |
| Issuance of PIPE shares | — | — | 7,500,000 | 1 | 74,999 | — | — | 75,000 |
| Warrant expense in connection with Merger | — | — | — | — | 154 | — | — | 154 |
| Issuance of Merger earn-out shares to common stockholders | — | — | 14,153,520 | 1 | — | — | — | 1 |
| Issuance of common stock for acquisition of businesses | — | — | 8,699,815 | 1 | 52,613 | — | — | 52,614 |
| Exercise of vested stock options | — | — | 1,382,978 | 1 | 1,258 | — | — | 1,259 |
| Vesting of early exercised stock options, net of cancelations | — | — | (2,812) | — | 227 | — | — | 227 |
| Stock-based compensation | — | — | — | — | 67,767 | — | — | 67,767 |
| Issuance of common stock upon vesting of RSUs, net of shares withheld for taxes | — | — | 1,189,786 | — | — | — | — | — |
| Payments for taxes related to net share settlement of equity awards | — | — | — | — | (5,998) | — | — | (5,998) |
| Issuance of common stock upon Class A common stock warrant redemption | — | — | 1,958,615 | — | 16,967 | — | — | 16,967 |
| Other comprehensive loss | — | — | — | — | — | (126) | — | (126) |
| Net loss | — | — | — | — | — | — | (107,659) | (107,659) |
| Balance as of December 31, 2021 | — | — | 204,791,986 | 20 | 613,687 | (137) | (278,951) | 334,619 |
| Issuance of common stock upon vesting of RSUs, net of shares withheld for taxes | — | — | 1,632,111 | — | — | — | — | — |
| Payments for taxes related to net share settlement of equity awards | — | — | — | — | (3,901) | — | — | (3,901) |
| Exercise of vested stock options | — | — | 1,611,687 | 1 | 2,245 | — | — | 2,246 |
| Vesting of early exercised stock options | — | — | — | — | 197 | — | — | 197 |
| Issuance of common stock under employee stock purchase plan | — | — | 393,528 | — | 1,178 | — | — | 1,178 |
| Stock-based compensation | — | — | — | — | 43,220 | — | — | 43,220 |
| Other comprehensive loss | — | — | — | — | — | (140) | — | (140) |
| Net loss | — | — | — | — | — | — | (65,678) | (65,678) |
| Balance as of December 31, 2022 | — | — | 208,429,312 | 21 | 656,626 | (277) | (344,629) | 311,741 |
| Issuance of common stock upon vesting of RSUs, net of shares withheld for taxes | — | — | 3,472,456 | — | — | — | — | — |
| Payments for taxes related to net share settlement of equity awards | — | — | — | — | (14,096) | — | — | (14,096) |
| Exercise of vested stock options | — | — | 1,222,548 | — | 2,322 | — | — | 2,322 |
| Issuance of common stock under employee stock purchase plan | — | — | 594,885 | — | 2,298 | — | — | 2,298 |
| Repurchases and retirement of common stock | — | — | (237,458) | — | (1,999) | — | — | (1,999) |
| Stock-based compensation | — | — | — | — | 67,156 | — | — | 67,156 |
| Other comprehensive income | — | — | — | — | — | 153 | — | 153 |
| Net loss | — | — | — | — | — | — | (23,546) | (23,546) |
| Balance as of December 31, 2023 | — | $— | 213,481,743 | $21 | $712,307 | $(124) | $(368,175) | $344,029 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.